Geneoscopy, a St. Louis-based developer of diagnostic tests for GI health, raised $105 million in Series B equity and debt funding, per Axios. Insiders Lightchain Capital and NT Investments co-led, and were joined by Morningside Ventures, Labcorp, Cultivation Capital, BioGenerator Ventures and Innovatus Capital Partners.
Geneoscopy Raises $105M in B Round
